Both in Biotechnology
Entera Bio vs Attovia Therapeutics
Over the past year ENTX returned +12.7% and ATTO returned −33.3%; their daily moves had a correlation of 0.14.
ENTX +12.7% ATTO −33.3%Growth of $1, one year, split-adjusted
| Metric | ENTX | ATTO |
|---|---|---|
| Price | $3.20 | $15.19 |
| Market cap | $556.6M | $693.4M |
| Today | +2.56% | −0.52% |
| 1 month | +10.7% | −14.6% |
| 6 months | +190.9% | — |
| Year to date | +64.9% | — |
| 1 year | +17.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | — |
| Short % of float | 3.5% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).